Reviews on
Prostate Cancer


Volume 7 Number 11
November 2019


Home > Disciplines > Publications > Reviews on Prostate Cancer > Volume 7, Year 2019 > Number 11, November



CONTENTS


DIAGNOSIS
EPIDEMIOLOGY, RISK FACTORS, PREVENTION
ETIOLOGY, PATHOGENESIS, PATHOLOGY
FOLLOW-UP, SIDE EFFECTS, QUALITY OF LIFE
INTEGRATIVE MEDICINE
OVERALL MANAGEMENT
PROGNOSIS
TREATMENT



DIAGNOSIS


Chatterjee A, Thomas S, Oto A.
Prostate MR: pitfalls and benign lesions.
Abdom Radiol (NY). 2019 Nov 8. doi: 10.1007/s00261-019-02302-x. [Epub ahead of print]
Source . Similar articles




Duffy MJ.
Biomarkers for prostate cancer: prostate-specific antigen and beyond.
Clin Chem Lab Med. 2019 Nov 12. doi: 10.1515/cclm-2019-0693. [Epub ahead of print]
Source . Similar articles




Engels RRM, Israël B, Padhani AR, Barentsz JO.
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition.
Eur Urol. 2019 Sep 30. doi: 10.1016/j.eururo.2019.09.021. [Epub ahead of print]
Source . Similar articles




Elsherif SB, Kuchana V, Aslam R, Kamat A, Bhosale PR, Klekers AR.
Locally advanced prostate cancer imaging findings and implications for treatment from the surgical perspective.
Abdom Radiol (NY). 2019 Nov 13. doi: 10.1007/s00261-019-02318-3. [Epub ahead of print]
Source . Similar articles




Henry A.
Using Multiparametric Magnetic Resonance Imaging to Shift Prostate Cancer Diagnosis Toward Clinically Significant Disease and Minimize Overdiagnosis (and Overtreatment).
Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):915-917. doi: 10.1016/j.ijrobp.2019.09.040.
Source . Similar articles




Israël B, Leest MV, Sedelaar M, Padhani AR, Zámecnik P, Barentsz JO.
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 2: Interpretation.
Eur Urol. 2019 Nov 23. doi: 10.1016/j.eururo.2019.10.024. [Epub ahead of print]
Source . Similar articles




Luiting HB, van Leeuwen PJ, Busstra MB, Brabander T, van der Poel HG, Donswijk ML, Vis AN, Emmett L, Stricker PD, Roobol MJ.
Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
BJU Int. 2019 Nov 4. doi: 10.1111/bju.14944. [Epub ahead of print]
Source . Similar articles




Mussi TC, Baroni RH, Zagoria RJ, Westphalen AC.
Prostate magnetic resonance imaging technique.
Abdom Radiol (NY). 2019 Nov 7. doi: 10.1007/s00261-019-02308-5. [Epub ahead of print]
Source . Similar articles




Nevo A, Navaratnam A, Andrews P.
Prostate cancer and the role of biomarkers.
Abdom Radiol (NY). 2019 Nov 13. doi: 10.1007/s00261-019-02305-8. [Epub ahead of print]
Source . Similar articles




Venderink W, Bomers JG, Overduin CG, Padhani AR, de Lauw GR, Sedelaar MJ, Barentsz JO.
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy.
Eur Urol. 2019 Nov 29. doi: 10.1016/j.eururo.2019.10.009. [Epub ahead of print]
Source . Similar articles



EPIDEMIOLOGY, RISK FACTORS, PREVENTION


Heidegger I, Tsaur I, Borgmann H, Surcel C, Kretschmer A, Mathieu R, Visschere P, Valerio M, van den Bergh RCN, Ost P, Tilki D, Gandaglia G, Ploussard G; EAU-YAU Prostate Cancer Working Party.
Hereditary prostate cancer - Primetime for genetic testing?
Cancer Treat Rev. 2019 Dec;81:101927. doi: 10.1016/j.ctrv.2019.101927. Epub 2019 Nov 11.
Source . Similar articles




Tharakan T, Bettocchi C, Carvalho J, Corona G, Joensen UN, Jones H, Kadioglu A, Martínez Salamanca JI, Serefoglu EC, Verze P, Darraugh J, Plass K, N'Dow J, Salonia A, Minhas S; EAU Working Group on Male Sexual and Reproductive Health.
Male Sexual and Reproductive Health-Does the Urologist Have a Role in Addressing Gender Inequality in Life Expectancy?
Eur Urol Focus. 2019 Nov 8. doi: 10.1016/j.euf.2019.10.009. [Epub ahead of print]
Source . Similar articles



ETIOLOGY, PATHOGENESIS, PATHOLOGY


O'Shea A, Kilcoyne A, Hedgire SS, Harisinghani MG.
Pelvic lymph nodes and pathways of disease spread in male pelvic malignancies.
Abdom Radiol (NY). 2019 Oct 31. doi: 10.1007/s00261-019-02285-9. [Epub ahead of print]
Source . Similar articles



FOLLOW-UP, SIDE EFFECTS, QUALITY OF LIFE


Ballon-Landa E, Panian J, Derweesh IH, McKay RR.
Management of bone complications in patients with genitourinary malignancies.
Urol Oncol. 2019 Oct 29. doi: 10.1016/j.urolonc.2019.09.028. [Epub ahead of print]
Source . Similar articles




El Badri SAM, Salawu A, Brown JE.
Bone Health in Men with Prostate Cancer: Review Article.
Curr Osteoporos Rep. 2019 Dec;17(6):527-537. doi: 10.1007/s11914-019-00536-8.
Source . Similar articles




Hebenstreit D, Pichler R, Heidegger I.
Drug-Drug Interactions in Prostate Cancer Treatment.
Clin Genitourin Cancer. 2019 May 27. doi: 10.1016/j.clgc.2019.05.016. [Epub ahead of print]
Source . Similar articles




Liang Z, Zhu J, Chen L, Xu Y, Yang Y, Hu R, Zhang W, Song Y, Lu Y, Ou N, Liu X.
Is androgen deprivation therapy for prostate cancer associated with cardiovascular disease? A meta-analysis and systematic review.
Andrology. 2019 Nov 19. doi: 10.1111/andr.12731. [Epub ahead of print]
Source . Similar articles




Liu R, Zhou J, Xia S, Li T.
Androgen Deprivation Therapy and the Risk of Stroke in Patients with Prostate Cancer: An Updated Systematic Review and Meta-Analysis.
Urol Int. 2019 Nov 20:1-8. doi: 10.1159/000503906. [Epub ahead of print]
Source . Similar articles



INTEGRATIVE MEDICINE


Kis B, Ifrim FC, Buda V, Avram S, Pavel IZ, Antal D, Paunescu V, Dehelean CA, Ardelean F, Diaconeasa Z, Soica C, Danciu C.
Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.
Int J Mol Sci. 2019 Nov 25;20(23). pii: E5905. doi: 10.3390/ijms20235905.
Source . Similar articles




Lai SW, Kuo YH, Liao KF.
Statins use and prostate cancer mortality.
Eur J Cancer. 2020 Jan;124:219-220. doi: 10.1016/j.ejca.2019.09.017. Epub 2019 Oct 31.
Source . Similar articles




Reglero C, Reglero G.
Precision Nutrition and Cancer Relapse Prevention: A Systematic Literature Review.
Nutrients. 2019 Nov 16;11(11). pii: E2799. doi: 10.3390/nu11112799.
Source . Similar articles



OVERALL MANAGEMENT


Ghadjar P, Fiorino C, Munck Af Rosenschöld P, Pinkawa M, Zilli T, van der Heide UA.
ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer.
Radiother Oncol. 2019 Dec;141:5-13. doi: 10.1016/j.radonc.2019.08.027. Epub 2019 Oct 23.
Source . Similar articles




Hess-Busch Y, Hadaschik B, Hess J.
M0CRPC overview of management options.
World J Urol. 2019 Nov 5. doi: 10.1007/s00345-019-02997-z. [Epub ahead of print]
Source . Similar articles




Saad F, Canil C, Finelli A, Hotte SJ, Malone S, Shayegan B, So AI, Aaron L, Basappa NS, Conter HJ, Danielson B, Gotto G, Hamilton RJ, Izard JP, Kapoor A, Kolinsky M, Lalani AA, Lattouf JB, Morash C, Morgan SC, Niazi T, Noonan KL, Ong M, Rendon RA, Sehdev S, Hew H, Park-Wyllie L, Chi KN.
A Canadian consensus forum on the management of patients with advanced prostate cancer.
Can Urol Assoc J. 2019 Nov 5. doi: 10.5489/cuaj.6082. [Epub ahead of print]
Source . Similar articles



PROGNOSIS


Kishan AU, Chu FI, King CR, Seiferheld W, Spratt DE, Tran P, Wang X, Pugh SE, Sandler KA, Bolla M, Maingon P, De Reijke T, Nickols NG, Rettig M, Drakaki A, Liu ST, Reiter RE, Chang AJ, Feng FY, Sajed D, Nguyen PL, Kupelian PA, Steinberg ML, Boutros PC, Elashoff D, Collette L, Sandler HM.
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.
Eur Urol. 2019 Nov 10. doi: 10.1016/j.eururo.2019.10.008. [Epub ahead of print]
Source . Similar articles




Su S, Liu L, Li C, Zhang J, Li S.
Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and meta-analysis.
Int J Surg. 2019 Dec;72:146-153. doi: 10.1016/j.ijsu.2019.10.043. Epub 2019 Nov 9.
Source . Similar articles




Tao R, Dai J, Bai Y, Yang J, Sun G, Zhang X, Zhao J, Zeng H, Shen P.
The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis.
Radiat Oncol. 2019 Nov 9;14(1):197. doi: 10.1186/s13014-019-1384-z.
Source . Similar articles



TREATMENT


Blazevski A, Scheltema MJ, Amin A, Thompson JE, Lawrentschuk N, Stricker PD.
Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
BJU Int. 2019 Nov 14. doi: 10.1111/bju.14951. [Epub ahead of print]
Source . Similar articles




Cetin B, Ozet A.
The Potential for Chemotherapy-Free Strategies in Advanced Prostate Cancer.
Curr Urol. 2019 Oct;13(2):57-63. doi: 10.1159/000499292. Epub 2019 Oct 1.
Source . Similar articles




Connor MJ, Shah TT, Horan G, Bevan CL, Winkler M, Ahmed HU.
Cytoreductive treatment strategies for de novo metastatic prostate cancer.
Nat Rev Clin Oncol. 2019 Nov 11. doi: 10.1038/s41571-019-0284-3. [Epub ahead of print]
Source . Similar articles




Dell'Oglio P, Mottrie A, Mazzone E.
Robot-assisted radical prostatectomy vs. open radical prostatectomy: latest evidences on perioperative, functional and oncological outcomes.
Curr Opin Urol. 2020 Jan;30(1):73-78. doi: 10.1097/MOU.0000000000000688.
Source . Similar articles




Heidenreich A, Pfister D.
Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease.
Curr Opin Urol. 2020 Jan;30(1):90-97. doi: 10.1097/MOU.0000000000000691.
Source . Similar articles




Kamran SC, D'Amico AV.
Radiation Therapy for Prostate Cancer.
Hematol Oncol Clin North Am. 2020 Feb;34(1):45-69. doi: 10.1016/j.hoc.2019.08.017. Epub 2019 Oct 28.
Source . Similar articles




Leuva H, Sigel K, Zhou M, Wilkerson J, Aggen DH, Park YA, Anderson CB, Hsu TM, Langhoff E, McWilliams G, Drake CG, Simon R, Bates SE, Fojo T.
A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide.
Semin Oncol. 2019 Aug - Oct;46(4-5):351-361. doi: 10.1053/j.seminoncol.2019.11.004. Epub 2019 Nov 16.
Source . Similar articles




Malinowski B, Wiciński M, Musiała N, Osowska I, Szostak M.
Previous, Current, and Future Pharmacotherapy and Diagnosis of Prostate Cancer-A Comprehensive Review.
Diagnostics (Basel). 2019 Oct 25;9(4). pii: E161. doi: 10.3390/diagnostics9040161.
Source . Similar articles




Maurer T, Graefen M, van der Poel H, Hamdy F, Briganti A, Eiber M, Wester HJ, van Leeuwen FWB.
Prostate-Specific Membrane Antigen-Guided Surgery.
J Nucl Med. 2020 Jan;61(1):6-12. doi: 10.2967/jnumed.119.232330. Epub 2019 Nov 15.
Source . Similar articles




Morris MJ, Corey E, Guise TA, Gulley JL, Kevin Kelly W, Quinn DI, Scholz A, Sgouros G.
Radium-223 mechanism of action: implications for use in treatment combinations.
Nat Rev Urol. 2019 Dec;16(12):745-756. doi: 10.1038/s41585-019-0251-x. Epub 2019 Nov 11.
Source . Similar articles




Otter SJ, Stewart AJ, Devlin PM.
Modern Brachytherapy.
Hematol Oncol Clin North Am. 2019 Dec;33(6):1011-1025. doi: 10.1016/j.hoc.2019.08.011. Epub 2019 Oct 1.
Source . Similar articles




Roviello G, Sobhani N, Corona SP, D'Angelo A.
Corticosteroid switch after progression on abiraterone acetate plus prednisone.
Int J Clin Oncol. 2019 Nov 8. doi: 10.1007/s10147-019-01577-w. [Epub ahead of print]
Source . Similar articles




Ruigrok EAM, van Weerden WM, Nonnekens J, de Jong M.
The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research.
Pharmaceutics. 2019 Oct 29;11(11). pii: E560. doi: 10.3390/pharmaceutics11110560.
Source . Similar articles




Sathianathen NJ, Koschel S, Thangasamy IA, Teh J, Alghazo O, Butcher G, Howard H, Kapoor J, Lawrentschuk N, Siva S, Azad A, Tran B, Bolton D, Murphy DG.
Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis.
Eur Urol. 2019 Oct 31. pii: S0302-2838(19)30693-1. doi: 10.1016/j.eururo.2019.09.004. [Epub ahead of print]
Source . Similar articles




Student S, Hejmo T, Poterała-Hejmo A, Leśniak A, Bułdak R.
Anti-androgen hormonal therapy for cancer and other diseases.
Eur J Pharmacol. 2020 Jan 5;866:172783. doi: 10.1016/j.ejphar.2019.172783. Epub 2019 Nov 8.
Source . Similar articles




Tran PT, Ost P.
Developments in oligometastatic hormone-sensitive prostate cancer.
World J Urol. 2019 Dec;37(12):2545-2547. doi: 10.1007/s00345-019-03009-w. Epub 2019 Nov 9.
Source . Similar articles




Zheng X, Zhao X, Xu H, Han X, Xu H, Dong X, Peng R, Yang L, Wei Q, Ai J.
Efficacy and safety of abiraterone and enzalutamide for castration-resistant prostate cancer: A systematic review and meta-analysis of randomized controlled trials.
Medicine (Baltimore). 2019 Nov;98(44):e17748. doi: 10.1097/MD.0000000000017748.
Source . Similar articles



bottom